by
Patricia Reaney
Reuters Health, Wednesday, July 23, 2003
LONDON (Reuters) - Older women may be
more prone to suffer from osteoporosis because they do not have enough
receptors, or chemical doorways, for the female hormone estrogen, scientists
said on Wednesday.
Osteoporosis, or brittle bone disease,
affects about one in three women and is more common after the menopause
when the body makes less estrogen.
Normally when a bone is subjected to
repeated mechanical stress, new bone cells compensate for the load.
But Professor Lance Lanyon and researchers at The Royal Veterinary
College in London have discovered that in transgenic mice lacking an
estrogen receptor called ER-alpha, this does not happen.
"It is the first time ER-alpha
has been implicated in bones' normal adaptive response to mechanical
loading," Lanyon said in an interview.
"The estrogen receptor is involved
in the response to mechanical loading which is responsible for establishing
and maintaining bone mass. We think that is the critical link why when
you take away the reproductive hormone, you lose bone," he added.
Hormone replacement therapy (HRT), which
replenishes the hormone loss after menopause, is prescribed to prevent
osteoporosis but it can increase the risk of heart disease, strokes
and some cancers.
"The rationale for why hormone
replacement therapy prevents osteoporosis is that if it has estrogen
in it, it maintains estrogen receptor numbers," said Lanyon.
But the disadvantage is that high estrogen
receptors in breast or uterine tissue could increase the likelihood
of developing cancer in those areas.
Lanyon believes his findings, which
are reported in the science journal Nature, could lead to the development
of new drugs that could enhance the performance of the receptor for
bone density without increasing cancer risk.
"The future trick would be to get
an organ or tissue-specific enhancement of estrogen receptor activity
just for the bones and not for the other tissues," he added.
Lanyon said the research points to a
specific therapeutic strategy to prevent osteoporosis and answers the
long-standing puzzle about why removing a reproductive hormone results
in bone loss.